ResearcherCharles UniversityActive in the last 2 years
Lubos B. Petruzelka
Matched on ORCID iD 0000-0002-4397-0635; OpenAlex author ID A5000705184. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 6
- Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. Co-author DOI 10.5507/bp.2023.049↗
- Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. Co-author DOI 10.4149/neo_2023_230409n193↗
- Novel biochemical markers for non-invasive detection of pancreatic cancer. Co-author DOI 10.4149/neo_2022_210730n1075↗
- [The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience]. First author DOI 10.14735/amko2017452↗
- Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience. Co-author DOI 10.4149/213_150611n326↗
- Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Co-author DOI 10.1080/01635581.2012.716138↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michal Vočka · 4 shared papers, 2017–2024 · strength 0.67
- Paper Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. DOI 10.5507/bp.2023.049↗
- Paper Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.4149/neo_2023_230409n193↗
- Paper Novel biochemical markers for non-invasive detection of pancreatic cancer. DOI 10.4149/neo_2022_210730n1075↗
- T Krechler · 4 shared papers, 2012–2024 · strength 0.45
- Paper Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. DOI 10.5507/bp.2023.049↗
- Paper Novel biochemical markers for non-invasive detection of pancreatic cancer. DOI 10.4149/neo_2022_210730n1075↗
- Paper Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: genera… DOI 10.4149/213_150611n326↗
- Aleš Žák · 3 shared papers, 2012–2024 · strength 0.38
- Paper Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis. DOI 10.5507/bp.2023.049↗
- Paper Novel biochemical markers for non-invasive detection of pancreatic cancer. DOI 10.4149/neo_2022_210730n1075↗
- Paper Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. DOI 10.1080/01635581.2012.716138↗
- Marta Kalousová · 2 shared papers, 2022–2024 · strength 0.35
- Tomáš Zima · 2 shared papers, 2022–2024 · strength 0.35
- P Hrabák · 2 shared papers, 2022–2024 · strength 0.35
- Z Krška · 2 shared papers, 2016–2023 · strength 0.23
- Paper Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.4149/neo_2023_230409n193↗
- Paper Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: genera… DOI 10.4149/213_150611n326↗
- David Hoskovec · 2 shared papers, 2016–2023 · strength 0.23
- Paper Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.4149/neo_2023_230409n193↗
- Paper Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: genera… DOI 10.4149/213_150611n326↗
- Pavel Záruba · 1 shared paper, 2023 · strength 0.17
- Jan Ulrych · 1 shared paper, 2023 · strength 0.17
- Soňa Argalácsová · 1 shared paper, 2023 · strength 0.17
- Miroslav Ryska · 1 shared paper, 2023 · strength 0.17
- Jan Bříza · 1 shared paper, 2016 · strength 0.06
- Lukáš Lambert · 1 shared paper, 2016 · strength 0.06
- M. Zeman · 1 shared paper, 2012 · strength 0.03
- Marek Vecka · 1 shared paper, 2012 · strength 0.03
- Jaroslav Macášek · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.